IP Library Granted Patent US 10,829,810
Granted Patent B2
US 10,829,810 · App. 15/720,467 · Granted Nov 10, 2020

Compositions on plasma-treated surfaces

Inventors: Byron J. Knight (San Diego, CA); David Opalsky (San Diego, CA)
Assignee: Gen-Probe Incorporated
C12Q1/686B01L3/5085C08J7/065C08J7/123C08J7/18B01L2200/12B01L2200/16B01L2300/161C08J2345/00G01N3/303
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,829,810
App. No.
15/720,467
Granted
Nov 10, 2020
Kind
B2
Abstract

The disclosure provides solid compositions such as lyophilisates adhered to surfaces such as plasma-treated surfaces and related methods, uses, kits, intermediates, starting materials, and downstream products.

Claims (16)

1. A method of forming a reconstitution mixture in a well of a plastic multiwell plate, the method comprising dispensing a reconstitution liquid onto a solid composition adhered to the well,

wherein the well is a plastic well comprising walls and a bottom that have been plasma-treated,

wherein the solid composition is a lyophilisate formed by dispensing a solution into the well and lyophilizing the solution, and

wherein, before dispensing the reconstitution liquid, the solid composition is sufficiently adhered to the bottom and walls of the well so as to remain substantially attached to the well following a package performance test in which the plastic multiwell plate comprising the well containing the solid composition is dropped from a height of about 20 mm to about 1000 mm onto a substrate.

2. The method of claim 1 , wherein the well comprises at least one of a polyethylene, polyethylene terephthalate, polypropylene, polymethacrylate, polyvinyl chloride, polystyrene, polyolefin, polycarbonate, polyurethane, starch-derived plastic, and cyclic olefin copolymer.

3. The method of claim 2 , wherein the well comprises cyclic olefin copolymer.

4. The method of claim 1 , wherein the well has a contact angle of about 5° to about 50°.

5. The method of claim 2 , wherein the well comprises polyolefin, and wherein the well has a surface energy from about 33 to about 45 dynes/cm.

6. The method of claim 2 , wherein the well comprises a polyethylene or polypropylene, and wherein the well has a surface energy from about 35 to about 55 dynes/cm.

7. The method of claim 1 , wherein a wall of the well has an angle from about 90 degrees to about 60 degrees.

8. The method of claim 1 , wherein the substrate comprises a soft material, a firm cushion material, a mat material, or a hard surface.

9. The method of claim 8 , wherein the substrate comprises a hard surface, and wherein the hard surface is stainless steel.

10. The method of claim 1 , wherein the solid composition comprises at least one of a bulking agent, an enzyme, an oligonucleotide, a buffer, a salt, nucleoside triphosphates, deoxynucleoside triphosphates, dATP, dGTP, dCTP, dTTP, dUTP, a capture probe, a hydrolysis probe, an RNase inhibitor, a chelating agent, a detergent, a polymerase, a pharmaceutically active agent, and reagents sufficient for performing a nucleic acid synthesis or amplification assay.

11. The method of claim 10 , wherein the solid composition comprises a bulking agent, and wherein the bulking agent comprises at least one of sucrose, mannitol, glycine, hydroxyethyl starch, raffinose, trehalose, and a saccharide.

12. The method of claim 1 , wherein the plasma treatment comprises a cold cathode discharge, hollow cathode discharge, DC-induced discharge, radio frequency (RF)-induced discharge, corona discharge, glow discharge, or charged particle beam.

13. The method of claim 1 , wherein the solid composition remains substantially attached when no visible part or less than about 10% or about 5% by volume of the solid composition becomes loose.

Assignments (5)
RELEASE OF SECURITY INTEREST RECORDED AT REEL/FRAME 043791/0031 Recorded Apr 23, 2026
From: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
To: HOLOGIC, INC.; GEN-PROBE INCORPORATED; CYNOSURE, LLC, AS SUCCESSOR-BY-CONVERSION TO CYNOSURE, INC.
Reel/Frame 075459/0575 →
SECURITY INTEREST Recorded Apr 8, 2026
From: BIOTHERANOSTICS, INC.; GEN-PROBE INCORPORATED; GEN-PROBE PRODESSE, INC.; CYTYC CORPORATION; SUROS SURGICAL SYSTEMS, INC.; GYNESONICS, INC.; BOLDER SURGICAL, LLC; FAXITRON BIOPTICS, LLC; HEALTH BEACONS, INC.; HOLOGIC, INC.
To: ROYAL BANK OF CANADA, AS COLLATERAL AGENT
Reel/Frame 075462/0440 →
SECURITY INTEREST Recorded Oct 12, 2021
From: HOLOGIC, INC.; FAXITRON BIOPTICS, LLC; BIOTHERANOSTICS, INC.; GEN-PROBE INCORPORATED; GEN-PROBE PRODESSE, INC.
To: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
Reel/Frame 057787/0526 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 1, 2018
From: KNIGHT, BYRON J.; OPALSKY, DAVID
To: GEN-PROBE INCORPORATED
Reel/Frame 047386/0678 →
SECURITY INTEREST Recorded Oct 5, 2017
From: HOLOGIC, INC.; GEN-PROBE INCORPORATED; CYNOSURE, INC.
To: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
Reel/Frame 043791/0031 →